Navigation Links
Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
Date:2/1/2012

NEW YORK, Feb. 1, 2012 /PRNewswire-USNewswire/ -- The Galien Foundation announced today open enrollment for the annual Prix Galien USA Awards to recognize outstanding achievement in improving the human condition through the development of innovative medical treatments and drug therapies. The 2012 awards ceremony will be held on October 16th in New York City. Awards will be bestowed for products in the following categories; Best Pharmaceutical Agent, Best Biotechnology Product, and Best Medical Technology. Companies seeking to enter the awards program must submit an entry by May 30th, 2012 to be eligible for consideration. Entry applications can be submitted online at www.prix-galien-usa.com.

(Photo: http://photos.prnewswire.com/prnh/20120201/DC44432-a )

(Logo:  http://photos.prnewswire.com/prnh/20120201/DC44432LOGO-b )

The ceremony will also include special honors to select individuals who have served to better humanity -- entitled the ProBono Humanum Award.

About the Awards
The Prix Galien Award was created to honor medical research and pharmacology. Considered the biomedical industry's equivalent of the Nobel Prize, the Prix Galien is the highest industry honor for outstanding efforts to improve the human condition though approval of innovative treatments and medicines. Past product award recipients include; Prevnar 13® (Pfizer 2011), Stelara® (Janssen 2011), Prolia®/XGEVA® (Amgen 2011), Coartem® (Novartis 2010), RotaTeq® (Merck 2010), xTAG® (Luminex 2010), Gleevec® (Novartis 2009), Nplate® (Amgen 2009), Promacta® (GSK 2009), Cellsearch® (Veridex 2009), Isentress® (Merck 2009), Selzentry® (Pfizer 2008), Solis® (Alexion 2008), Infuse® (Wyeth 2008), Revlimid® (Celgene 2008), Januvia® (Merck 2007), Chantix® (Pfizer 2007), Humira® (Abbott 2007) and Gardisil® (Merck 2007).

The ProBono Humanum Award recognizes exemplary efforts by individuals and organizations in helping mankind. The award will be presented by Professor Elie Wiesel, a Nobel Prize Laureate. Previous winners of the award include: Professor Paul Farmer (2011), President Bill Clinton and Philippe Douste-Blazy (2010); Professors Barry Bloom and Jeffrey Sachs (2009), Sheldon Segal and the Population Council (2008); and Dr. Roy Vagelos (2007). For more information visit www.galienfoundation.org.

CONTACT:
John Mohr
The Galien Foundation
+1-973-809-5582
jgmohr@galienfoundation.org


'/>"/>
SOURCE Galien Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Prix Galien USA Announces 2008 Final Candidates
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
4. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
5. Prix Galien USA Announces 2009 Final Candidates
6. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
7. ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan
8. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
9. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
10. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
11. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... YORK , May 19, 2016 ... space will fully recover given the relentless pressures in ... for sure in the investors circle though - numerous ... due-diligence. Ahead of today,s session, ActiveWallSt.com,s presents four names ... PTLA ), Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ...
(Date:5/19/2016)... 2016 Regen BioPharma, ... RGBPP) announced today initiation of a preclinical development ... based cancer immunotherapeutic product leveraging its NR2F6 immunological ... a generation of cord blood derived killer cells ...  The product in development will be a "universal ...
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels ... Villalobos Award to Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. ... financed by one of ACA’s member angel groups. It is the highest honor available ...
(Date:5/18/2016)... , May 18, 2016 The ... it does not mean that there are no opportunities ahead. ... Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics Inc. ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ). ... alerts at: http://www.activewallst.com/ Threshold ...
Breaking Biology Technology:
(Date:3/11/2016)... March 11, 2016 --> ... research report "Image Recognition Market by Technology (Pattern Recognition), ... Advertising), by Deployment Type (On-Premises and Cloud), by Industry ... published by MarketsandMarkets, the global market is expected to ... 29.98 Billion by 2020, at a CAGR of 19.1%. ...
(Date:3/10/2016)... 10, 2016   Unisys Corporation (NYSE: UIS ... (CBP) is testing its biometric identity solution at the ... to help identify certain non-U.S. citizens leaving the country. ... designed to help determine the efficiency and accuracy of using ... and will run until May 2016. --> ...
(Date:3/9/2016)... , March 9, 2016 ... identified that more than 23,000 public service employees either ... been receiving their salary unlawfully.    --> ... government identified that more than 23,000 public service employees ... had been receiving their salary unlawfully.    --> ...
Breaking Biology News(10 mins):